Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniel D. De Carvalho"'
Autor:
Shengrui Feng, Daniel D. De Carvalho
Publikováno v:
The FEBS Journal. 289:1214-1239
The appropriate coordination between epigenetic regulators is essential for spatial and temporal regulation of gene expression and maintenance of cell identity. Cancer is a disease driven by both genetic and epigenetic alterations. The widespread dys
Autor:
Wail Ba-alawi, Evelyne Lima-Fernandes, Jason W. Locasale, Daniel D. De Carvalho, Paul Savage, Ilias Ettayebi, Hellen Kuasne, Morag Park, Felicia Tai, Yunchi Ingrid Kao, Benjamin Haibe-Kains, Alexandra N. Fedor, Paul Guilhamon, Giacomo Grillo, Seyed Ali Madani Tonekaboni, Cheryl H. Arrowsmith, Xiaojing Liu, Constanza Martinez, Anne-Marie Fortier, Mathieu Lupien, Alex Murison, Geneviève Deblois, David W. Cescon
Publikováno v:
Cancer Discovery. 10:1312-1329
Tumor progression upon treatment arises from preexisting resistant cancer cells and/or adaptation of persister cancer cells committing to an expansion phase. Here, we show that evasion from viral mimicry response allows the growth of taxane-resistant
Publikováno v:
Pharmacologytherapeutics. 205
DNA methylation patterns are frequently altered in cancer cells as compared to normal cells. A large body of research associates these DNA methylation aberrations with cancer initiation and progression. Moreover, cancer cells seem to depend upon thes
Autor:
Gareth E. Jones, Katia B Pagnano, Fabíola Attié de Castro, Beatriz F Ribeiro, Nelson Hamerschlak, Luiz Roberto Sardinha, Maria Emilia Zenteno, Yolanda Calle, Jacqueline F. Jacysyn, Daniel D. De Carvalho, Gustavo P. Amarante-Mendes, Maria Aparecida Zanichelli, Welbert Oliveira Pereira
Publikováno v:
Pereira, W O, De Carvalho, D D, Zenteno, M E, Ribeiro, B F, Jacysyn, J F, Sardinha, L R, Zanichelli, M A, Hamerschlak, N, Pagnano, K B, Jones, G E, Castro, F A, Amarante-Mendes, G P & Calle, Y 2017, ' BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy ', Cell Death & Disease, vol. 8, no. 10, pp. e3114 . https://doi.org/10.1038/cddis.2017.458
Cell Death & Disease
Cell Death & Disease
Chronic myeloid leukemia (CML) is a myeloproliferative disease caused by the BCR–ABL1 tyrosine kinase (TK). The development of TK inhibitors (TKIs) revolutionized the treatment of CML patients. However, TKIs are not effective to those at advanced p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::000b2b709b907f61aa002affee8a544e
https://kclpure.kcl.ac.uk/ws/files/80348220/Pereira_et_al_Cell_Death_Disease_2017.pdf
https://kclpure.kcl.ac.uk/ws/files/80348220/Pereira_et_al_Cell_Death_Disease_2017.pdf